Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
2002-10-17
pubmed:abstractText
Immunostaining for p53 commonly is considered a marker of neoplasia. Previous studies of nonneoplastic processes have yielded conflicting results.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
0148-396X
pubmed:author
pubmed:issnType
Print
pubmed:volume
51
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1246-54; discussion 1254-5
pubmed:dateRevised
2005-11-17
pubmed:meshHeading
pubmed-meshheading:12383370-Astrocytoma, pubmed-meshheading:12383370-Brain Diseases, pubmed-meshheading:12383370-Brain Neoplasms, pubmed-meshheading:12383370-Cerebral Infarction, pubmed-meshheading:12383370-DNA Mutational Analysis, pubmed-meshheading:12383370-Demyelinating Diseases, pubmed-meshheading:12383370-Encephalitis, Herpes Simplex, pubmed-meshheading:12383370-Gliosis, pubmed-meshheading:12383370-Humans, pubmed-meshheading:12383370-Immunohistochemistry, pubmed-meshheading:12383370-Leukoencephalopathy, Progressive Multifocal, pubmed-meshheading:12383370-Nuclear Proteins, pubmed-meshheading:12383370-Proto-Oncogene Proteins, pubmed-meshheading:12383370-Proto-Oncogene Proteins c-mdm2, pubmed-meshheading:12383370-Reference Values, pubmed-meshheading:12383370-Tumor Suppressor Protein p53
pubmed:year
2002
pubmed:articleTitle
p53 in nonneoplastic central nervous system lesions: an immunohistochemical and genetic sequencing study.
pubmed:affiliation
Department of Pathology, Marmara University School of Medicine, Istanbul, Turkey.
pubmed:publicationType
Journal Article